Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico…
Clinical
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Acquisitions
X-Vax Technology Appoints Isaac Blech as Vice Chairman to its Board…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Clinical
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Clinical
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement…
Clinical
Medicine Supply Notification: Ketotifen 1mg/5ml elixir (Zaditen) – FirstWord Pharma
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Sanofi eyes acquisitions in US, including Principia Biopharma: report – FirstWord…
Clinical
Lilly’s mirikizumab superior to Novartis’ Cosentyx in psoriasis study – FirstWord…
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Clinical
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Home
Clinical
Launch
Launch
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Launch
Idorsia establishes US commercial operations and leadership team Swiss Stock Exchange:IDIA
Globenewswire News
-
July 16, 2020
Launch
Evofem Biosciences Announces Peer-Reviewed Publication of the Pivotal Phase 3 AMPOWER Study Results For Phexxi (lactic acid, citric acid and potassium bitartrate) in Contraception...
Launch
Ocular Therapeutix Announces Its First Published Physician Fee Schedule for Administration of Intracanalicular Inserts
Launch
Sanofi And MD Anderson Announce Strategic Collaboration To Accelerate Oncology Research And Development
Launch
Aleafia Health Provides Update on Strategic Growth Initiatives Other OTC:ALEAF
Launch
Merck & Co. signs cancer drug-development deal with Foghorn Therapeutics –...
Firstwordpharma News
-
July 9, 2020
0
Launch
CorMedix Inc. Reports Submission of Defencath New Drug Application – FirstWord...
Firstwordpharma News
-
July 9, 2020
0
Launch
Otsuka Pharmaceutical Development & Commercialization, Inc. Launches NephU, an Online Healthcare...
Biospace News
-
July 8, 2020
0
Launch
Evive Biotech Sees Positive Results in Phase III Trial for CIN...
Biospace News
-
July 8, 2020
0
Launch
REGENXBIO Provides Update on Progress of Clinical Programs for Rare Genetic...
Biospace News
-
July 8, 2020
0
1
2
3
...
30
Page 1 of 30
- Advertisement -
MOST POPULAR
Three-pronged attack can overcome drug resistance in bowel cancer
March 25, 2019
Homology Medicines Announces Peer-Reviewed Publication Demonstrating its AAVHSC Vectors Crossed the...
November 26, 2019
NICE and the SMC approve Mulpleo (lusutrombopag) for the treatment of...
December 12, 2019
Moffitt Cancer Center Partners with TuHURA Biopharma Inc. to Develop a...
May 29, 2019
Load more
HOT NEWS
Others
Promore Pharma has finalized recruitment of patients in HEAL LL-37 early
Commercial
Mammoth Biosciences Raises $45 Million to Build Next Generation CRISPR Products...
Phase II
Berlin Cures’ Steering Committee is Assembled to Facilitate the Design and...
Commercial
Aprea Therapeutics Adds New Investor to Series C Financing
